Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction
- 1 February 2016
- journal article
- Published by American Physiological Society in Physiological Genomics
- Vol. 48 (2) , 124-134
Abstract
The ligand activated nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) in the endothelium regulates vascular function and blood pressure (BP). We previously reported that transgenic mice (E-V290M) with selectively targeted endothelial-specific expression of dominant negative PPARγ exhibited endothelial dysfunction when treated with a high-fat diet, and exhibited an augmented pressor response to angiotensin II (ANG II). We hypothesize that interference with endothelial PPARγ would exacerbate ANG II-induced endothelial dysfunction. Endothelial function was examined in E-V290M mice infused with a subpressor dose of ANG II (120 ng·kg−1·min−1) or saline for 2 wk. ANG II infusion significantly impaired the responses to the endothelium-dependent agonist acetylcholine both in basilar and carotid arteries from E-V290M but not NT mice. This impairment was not due to increased BP, which was not significantly different in ANG II-infused E-V290M compared with NT mice. Superoxide levels, and expression of the pro-oxidant Nox2 gene was elevated, whereas expression of the anti-oxidant genes Catalase and SOD3 decreased in carotid arteries from ANG II-infused E-V290M mice. Increased p65 and decreased Iκ-Bα suggesting increased NF-κB activity was also observed in aorta from ANG II-infused E-V290M mice. The responses to acetylcholine were significantly improved both in basilar and carotid arteries after treatment with Tempol (1 mmol/l), a scavenger of superoxide. These findings provide evidence that interference with endothelial PPARγ accelerates ANG II-mediated endothelial dysfunction both in cerebral and conduit arteries through an oxidative stress-dependent mechanism, suggesting a role for endothelial PPARγ in protecting against ANG II-induced endothelial dysfunction.Keywords
Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) (HL048058, HL062984, HL084207, HL125603, HL062984, HL113863)
- American Heart Association (AHA) (15SFRN23480000)
- U.S. Department of Veterans Affairs (VA) (BX001399)
- Fondation Leducq
- Roy J. Carver Charitable Trust
This publication has 65 references indexed in Scilit:
- Protecting against vascular disease in brainAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunctionBasic Research in Cardiology, 2011
- The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Vascular Endothelial Function and Hypertension: Insights and DirectionsCurrent Hypertension Reports, 2010
- Disruption of endothelial peroxisome proliferator-activated receptor-γ reduces vascular nitric oxide productionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and PathophysiologyAntioxidants & Redox Signaling, 2009
- Endothelium-Specific Interference With Peroxisome Proliferator Activated Receptor Gamma Causes Cerebral Vascular Dysfunction in Response to a High-Fat DietCirculation Research, 2008
- Interference with PPARγ Function in Smooth Muscle Causes Vascular Dysfunction and HypertensionCell Metabolism, 2008
- NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbitsCardiovascular Research, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001